Huuskonen · Frontiers in immunology 2021 · Controlled laboratory animal experiment · n=?

Air Pollution Particulate Matter Amplifies White Matter Vascular Pathology and Demyelination Caused by Hypoperfusion.

Cited 33 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Preclinical animal model research without human subjects

PubMed 34868068 · doi:10.3389/fimmu.2021.785519 · record verified 2026-08-30

What was done

C57BL/6 mice were exposed to either filtered air or urban traffic nanoparticulate matter (nPM; aerodynamic diameter ≤200 nm), with and without bilateral carotid artery stenosis (BCAS) to induce cerebral hypoperfusion. Brain vascular and structural alterations were assessed using multiparametric MRI (including dynamic susceptibility contrast MRI and diffusion metrics) and histochemistry.

What was found

The abstract reports no numerical values. nPM exposure alone did not alter regional cerebral blood flow (CBF) or blood-brain barrier (BBB) integrity. In mice with BCAS, nPM worsened white matter hypoperfusion (decreased CBF on DSC-MRI), exacerbated BBB permeability (extravascular IgG deposits), and aggravated abnormal white matter MRI diffusion metrics. Axonal density was reduced equally in BCAS cohorts regardless of nPM status, whereas nPM exposure induced white matter demyelination both with and without hypoperfusion.

Why it matters

This study provides experimental evidence that airborne particulate matter can synergize with underlying cerebral hypoperfusion to accelerate white matter pathology and demyelination, suggesting a mechanism by which air pollution may augment vascular dementia risk in vulnerable populations.

Limits

This is a preclinical animal study in mice, limiting direct clinical translation. The abstract does not report the sample size, particulate concentration, exposure duration, or functional/behavioral cognitive endpoints.

Cited by